Education, Science, Technology, Innovation and Life
Open Access
Sign In

Practical Tracking System of Intelligent Workshop Product Based on Wireless Sensor Network

Download as PDF

DOI: 10.23977/acss.2023.070114 | Downloads: 16 | Views: 566

Author(s)

Fangling Liu 1, Jun Li 2, Yuewen Wang 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, 712046, Shaanxi, China
2 School of Basic Sciences, Shaanxi University of Chinese Medicine, Xianyang, 712046, Shaanxi, China

Corresponding Author

Jun Li

ABSTRACT

As one of the traditional theories of traditional Chinese medicine, the theory of collaterals has a significant effect in the treatment of cardiovascular diseases. According to the initial link of atherosclerosis -- vascular endothelial damage, guided by the theory of collaterals disease, from the two perspectives of the vein vacuity and vein obstruction, Buyang Huanwu Decoction of tonifying Qi and promoting blood circulation and collaterals and Gualsankyx Baibanxia Decoction of eliminating phlegm and removing blood stasis and collaterals and Xuefuzhuyu Decoction are respectively given.Based on the past experimental demonstration, this paper aims to provide new ideas for clinical diagnosis and treatment.

KEYWORDS

Theory of collaterals, Atherosclerosis, Endothelial injury, Traditional chinese medicine

CITE THIS PAPER

Fangling Liu, Jun Li, Yuewen Wang. Practical Tracking System of Intelligent Workshop Product Based on Wireless Sensor Network. Advances in Computer, Signals and Systems (2023) Vol. 7: 108-114. DOI: http://dx.doi.org/10.23977/acss.2023.070114.

REFERENCES

[1] Kobiyama K.,Ley K. "Atherosclerosis". Circ.Res., vol. 123, no. 10, pp. 1118-1120, 2018.
[2] Wang R.,Wang M.,Ye J., et al. "Mechanism overview and target mining of atherosclerosis: Endothelial cell injury  in atherosclerosis is regulated by glycolysis (Review)". Int. J. Mol. Med., vol. 47, no. 1, pp. 65-76, 2021.
[3] Dicker K. T.,Gurski L. A.,Pradhan-Bhatt S., et al. "Hyaluronan: a simple polysaccharide with diverse biological functions". Acta Biomater., vol. 10, no. 4, pp. 1558-70, 2014.
[4] Libby P.,Bornfeldt K. E.,Tall A. R. "Atherosclerosis: Successes, Surprises, and Future Challenges". Circ.Res., vol. 118, no. 4, pp. 531-4, 2016.
[5] Eelen G.,de Zeeuw P.,Treps L., et al. "Endothelial Cell Metabolism". Physiol. Rev., vol. 98, no. 1, pp. 3-58, 2018.
[6] Yu Ruizhui, Lv Xiaodong, Pang Lijian, et al. "Discussion on collateral diseases and Tongluo medicine by using image thinking of traditional Chinese medicine". China Journal of Traditional Chinese Medicine and Pharmacy, vol. 37, no. 02, pp. 750-752, 2022.
[7] Yang Dandan, Wang Fengrong. "Overview and Analysis of Collateral Disease Theory". Liaoning Journal of Traditional Chinese Medicine, vol. 20, no. 08, pp. 188-190, 2018.
[8] Zhang Fuli, Chi Mingyang, Zhang Jian. "Discussion on the theory and clinical significance of Ye Tianshi's "Injecting collaterals through Qi and restoring Qi through meridian" ". Journal of Traditional Chinese Medicine, vol. 48, no. 03, pp. 61-64, 2020.
[9] Yang Chuanhua, MA Ning. " Examination on "Choroid" and "Blood Collages" in Lingshu Classic", 2011•Proceedings of Chinese Medical Doctor Association Physicians Conference of Integrated Traditional and Western Medicine, Guangzhou, Guangdong, China,  2011, pp. 366-372.
[10] Ma Shuran, Liu Yanchi. "Heart main blood collaterals Theory". China Journal of Traditional Chinese Medicine and Pharmacy, no. 04, pp. 14-16, 2000.
[11] Wu Yiling. "Theory of TCM Collaterals and three-dimensional network system". Journal of Traditional Chinese Medicine, no. 06, pp. 407-409, 2003.
[12] Wu Yiling. "Discussion on the correlation of "chorovascular system" ". Journal of Traditional Chinese Medicine, no. 01, pp. 5-8, 2007.
[13] Li Miao, Wang Lili, Chang Bingmei. "Advances in research on the mechanism of vascular endothelial cell function injury". Chinese Journal of Arteriosclerosis, vol. 27, no. 08, pp. 730-736, 2019.
[14] Wu Yiling. "Analysis on the etiology of collateral disease". Chinese Journal of Difficult and Complicated Cases, no. 04, pp. 215-217, 2004.
[15] Wu Yiling. "The pathogenesis and change of collaterals disease". Chinese Journal of Difficult and Complicated Cases, no. 05, pp. 282-284, 2004.
[16] Ross R. "The pathogenesis of atherosclerosis: a perspective for the 1990s". Nature, vol. 362, no. 6423, pp. 801-9, 1993.
[17] Wu Yiling. "The pathogenesis of collaterals disease". Journal of Traditional Chinese Medicine, no. 04, pp. 243-245, 2005.
[18] Fu Xinying, Sun Zhengji, Zhang Wei. "Discussion on Prevention and Treatment Strategy of Atherosclerosis with Traditional Chinese Medicine Based on "the Theory of Endothelial Injury" ". World Chinese Medicine, vol. 16, no. 11, pp. 1759-1763, 2021.
[19] Gimbrone M. J.,García-Cardeña G. "Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis". Circ.Res., vol. 118, no. 4, pp. 620-36, 2016.
[20] Mudau M.,Genis A.,Lochner A., et al. "Endothelial dysfunction: the early predictor of atherosclerosis". Cardiovasc. J. Afr., vol. 23, no. 4, pp. 222-31, 2012.
[21] Brix B.,Mesters J. R.,Pellerin L., et al. "Endothelial cell-derived nitric oxide enhances aerobic glycolysis in astrocytes  via HIF-1α-mediated target gene activation". J. Neurosci., vol. 32, no. 28, pp. 9727-35, 2012.
[22] Sitia S.,Tomasoni L.,Atzeni F., et al. "From endothelial dysfunction to atherosclerosis". Autoimmun. Rev., vol. 9, no. 12, pp. 830-4, 2010.
[23] Li Hongrong, Mi Hongying, Sun Ying, et al. "Understanding of Etiology and Pathogenesis of Atherosclerosis Based on Collateral Theory". Journal of Traditional Chinese Medicine, vol. 58, no. 16, pp. 1359-1363+1367, 2017.
[24] Song Hongxia. "Clinical observation on the adjuvant treatment of coronary atherosclerotic heart disease with Buyang Huanwu Decoction". China's Naturopathy, vol. 30, no. 08, pp. 73-76, 2022.
[25] Zhou Xiaoling, Du Yanhua, Chen Xiaohui, et al. "Clinical study of Buyang Huanwu Decoction combined with Atorvastatin in the treatment of angina pectoris of coronary heart disease". Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease, vol. 18, no. 04, pp. 650-652, 2020.
[26] Jiang Peixi, Li Zhongye. "Research progress of Buyang Huanwu Decoction in the intervention of vascular endothelial injury". Journal of Guangxi University of Chinese Medicine, vol. 16, no. 03, pp. 61-63, 2013.
[27] Liu Zhiyong, You Yu, Liu Yuhui, et al. "Protective effects of Buyang Huanwu Tang on anti-endothelial cell injuries through regulating MAPK signaling pathways of human umbilical vein endothelial cells". The Chinese Journal of Clinical Pharmacology, vol. 32, no. 22, pp. 2098-2103, 2016.
[28] You Xinyi, Wang Wenfeng, Xu Xia, et al. "Research Progress on the Material Foundation and Mechanism of Buyang Huanwu Decoction in the Treatment of Atherosclerosis ". Traditional Chinese Drug Research and Clinical Pharmacology, vol. 32, no. 10, pp. 1575-1581, 2021.
[29] Zhou Tingting. "Clinical evaluation of Gualsanthoxiebaibanxia Decoction combined with Xuefu Zhuyu Decoction in patients with phlegm-stasis interjunction coronary heart disease". Chronic Pathematology Journal, vol. 20, no. 12, pp. 1862-1863+1866, 2019.
[30] Jiang Weiming. "Clinical observation of Gualou Xiebai Banxia Decoction combined with Xuefu Zhuyu Decoction in treating phlegm-stasis interjunction syndrome of angina pectoris of coronary heart disease". Guangming Journal of Chinese Medicine, vol. 36, no. 01, pp. 56-58, 2021.
[31] Li Jinxi, Zhao Jiyan, Wang Junning, et al. "Effect and Action Mechanism of Gualou Xiebai Banxia Decoction on Atherosclerosis in ApoE-/-mice". Acta Chinese Medicine and Pharmacology, vol. 48, no. 02, pp. 25-30, 2020.
[32] Shen Zhongqi. "Based on ALK1-LDL pathway to explore the mechanism of Gualou Xiebai Banxia Decoction in alleviating ox-LDL-induced vascular endothelial cell injury", Shandong University of Traditional Chinese Medicine, 2021.
[33] Wang Qi, Chen Yunbo, Lai Shilong, et al. "Effects of Xuefu Zhuyu Decoction on the Morphological Features of Vascular Endothelial Cells Injured by Serum of Blood-stasis-syndrome Rabbits". Journal of Guangzhou University of Traditional Chinese Medicine, no. 02, pp. 105-108+114, 2001.
[34] Wang Qi, Chen Yunbo, Lai Shilong, et al. "Effects of Xuefu Zhuyu Decoction on Endocrine Function of the Vascular Endothelial Cells Injured by Rabbit Stasis Syndrome Serum". Chinese Journal of Experimental Traditional Medical Formulae, no. 02, pp. 12-14, 2002.
[35] Geng Zhaohui, Huang Wei, Gao Weimin, et al. "The Effect of Xuefu Zhuyu Decoction on Attenuation of the Atherosclerosis in the Rats with Atherosclerosis". Journal of Shandong Agricultural University(Natural Science Edition), vol. 42, no. 02, pp. 211-214+218, 2011.
[36] Geng Zhaohui, Shou Baodong, Liu Hui, et al. "Geng Zhaohui, Huang Wei, Gao Weimin". Journal of Hebei University(Natural Science Edition), vol. 31, no. 03, pp. 304-308, 2011.
[37] Dong Chao, Huang Wei, Geng Zhaohui, et al. "Effects of Xuefu Zhuyu decoction on intercellular adhesion molecule and lipid peroxidation of experimental atherosclerosis rats". Journal of Hebei University(Natural Science Edition), vol. 32, no. 06, pp. 650-654, 2012.
[38] Zhang Wei, Liu Xiaodan, Li Fei, et al. "Influence of Xuefuzhuyu decoction on EPC repairing injured vascular endothelium". Chinese Pharmacological Bulletin, vol. 32, no. 03, pp. 427-433, 2016.

Downloads: 20222
Visits: 309073

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.